IL17A and metabolic dysfunction-associated steatohepatitis: –↓ lipid droplet formation (TEC being more effective than C3Glu);–↓ the release of IL-6, TNF-α, IL-10, IL-17, and IL-4;–↑ TLR4 expression in the NASH model compared to the control group, but TEC effectively reversed this increase;–↓ inflammatory mediators, TLR4, and LDH release levels.